LEO 152020 tablet

DRUG2 trials

Sponsors

JW Pharmaceutical

Conditions

Atopic DermatitisHealthy

Phase 1

A Trial to Evaluate the Effect of Food on LEO 152020

CompletedNCT04203836

JW PharmaceuticalHealthy

Start: 2020-01-09End: 2020-12-12Updated: 2024-04-22

Phase 2

Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis

CompletedNCT05117060

JW PharmaceuticalAtopic Dermatitis

Start: 2021-12-13End: 2023-07-26Updated: 2024-06-04